Abstract
BackgroundThe availability of new biologic treatments that directly target components of the RA inflammatory cascade had transformed management of this disease over the last 10 years. While these agents have...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
